Chemical Compound

2-pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-n-methyl-;sorafenib;4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-n-methyl-2-pyridinecarboxamide;2-pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-n-methyl- sorafenib 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-n-methyl-2-pyridinecarboxamide

CAS Registry Number 284461-73-0
返回搜索 申请报价
2-pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-n-methyl-;sorafenib;4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-n-methyl-2-pyridinecarboxamide;2-pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-n-methyl- sorafenib 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-n-methyl-2-pyridinecarboxamide 结构式
Primary record

2-pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-n-methyl-;sorafenib;4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-n-methyl-2-pyridinecarboxamide;2-pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-n-methyl- sorafenib 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-n-methyl-2-pyridinecarboxamide

库存
9,523 克
纯度
99.0 %
CAS
284461-73-0

化合物标识与属性

CAS
284461-73-0
PubChem CID
216239
SMILES
CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
Canonical SMILES
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1

名称与同义词

  • Sorafenib
  • Nexavar
  • 284461-73-0
  • Sorafenib tosylate
  • sorafenibum
  • Donafenib
  • Sorafenib [INN]
  • Chemexper
  • Sorafenib-d3
  • Sorafinib
  • Xarelto
  • Sorafenib free base
  • MnTMPyP pentachloride
  • BAY 43-9006
  • Sorafenibtosylate
  • Sorafenib tosilate
  • 1uwh
  • 3gcs
  • 3heg
  • 4asd
  • Sorafenib (Base)
  • Sorafenib, 4
  • Hit compound, 8
  • Sorafenib (INN)
  • Nexavar (TN)
  • Sorafenib (Nexavar)
  • Sorafenib (Standard)
  • Kinome_766
  • SORAFENIB BASE
  • 9ZOQ3TZI87
  • RefChem:6252
  • UNII-9ZOQ3TZI87
  • C21H16ClF3N4O3
  • SORAFENIB [MI]
  • MFCD06411450
  • Sorafenib (USAN/INN)
  • SORAFENIB [USAN]
  • Nexavar (TN) (Bayer)
  • sorafenib tosilate hydrate
  • CHEMBL1336
  • SORAFENIB [VANDF]
  • Donafenib (Sorafenib D3)
  • DTXSID7041128
  • Sorafenib [USAN:INN:BAN]
  • D0W5HK
  • SORAFENIB [MART.]
  • AC1L50CF
  • SCHEMBL8218
  • SORAFENIB [WHO-DD]
  • BAY-43-9006
  • SORAFENIB [EMA EPAR]
  • CHEBI:50924
  • HSDB 8173
  • Sorafenib (Pan-TK inhibitor)
  • Sorafenib - Bio-X trade mark
  • 284461-73-0 (free base)
  • MLDQJTXFUGDVEO-UHFFFAOYSA-N
  • BAY 43-9006; Sorafenib
  • cid_216239
  • GTPL5711
  • orb1310944
  • QCR-65
  • BAY-439006
  • DTXCID5021128
  • SCHEMBL29349634
  • BDBM16673
  • Nexavar|||BAY 43-9006
  • 4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N-METHYLPICOLINAMIDE
  • L01XE05
  • SYN1082
  • 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide
  • VINYLDI-N-OCTYLMETHYLSILANE
  • BCPP000064
  • GLXC-90094
  • HMS2043A18
  • HMS3244A15
  • HMS3244A16
  • HMS3244B15
  • HMS3656N20
  • HMS5085J14
  • BAY 439006
  • BAY43-9006
  • K00597a
  • ACT06732
  • AOB87782
  • BCP01767
  • BCP34023
  • EX-A2894
  • Sorafenib, 98% - 10MG 10mg
  • ZINC1493878
  • AN-613
  • BAY439006
  • CID216239
  • CS0056
  • EBC-00643
  • HY-10201R
  • NP3268
  • NSC747971
  • NSC800934
  • RS0103
  • s7397
  • STK627350
  • 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
  • BAY-545-9085
  • Sorafenib for peak identification CRS
  • AKOS005560229
  • C21-H16-Cl-F3-N4-O3
  • AC-1674
  • ACN-032355
  • BAY 673472
  • BAY5459085
  • CCG-269400
  • CS-1590
  • CS-O-11744
  • DB00398
  • FS10807
  • ND-0224
  • NSC-724772
  • NSC-747971
  • NSC-800934
  • PB14443
  • SB19942
  • SDCCGSBI-0634413.P005
  • SF-0529
  • BAY 43 9006
  • BAY 5459085
  • BAY-43-0006
  • BAY-54-9085
  • KS-0000009E
  • NCGC00167488-01
  • NCGC00167488-02
  • NCGC00167488-03
  • NCGC00167488-04
  • NCGC00167488-05
  • NCGC00167488-07
  • NCGC00167488-11
  • NCGC00167488-14
  • 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
  • AK163019
  • BAY 545 9085
  • BAY 545-9085
  • BC679588
  • BP-44051
  • BS164413
  • DA-52659
  • EN002709
  • HY-10201
  • SC-19355
  • Sorafenib free base (BAY-43-9006)?
  • SY009239
  • EC 608-209-4
  • N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
  • 100012-18-8
  • AB0019677
  • AB1004622
  • LS-186067
  • LS-187021
  • LS-187788
  • PA-216239
  • 2161B
  • 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
  • A3009
  • A8245
  • AM20090614
  • FT-0650736
  • FT-0674632
  • NS00005946
  • SW202562-4
  • V0124
  • 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide
  • BA4 43 9006
  • J1.961.269D
  • C-8800
  • D08524
  • EN300-120647
  • J10391
  • 15216-EP2272827A1
  • 15216-EP2298778A1
  • 15216-EP2311840A1
  • 15216-EP2316832A1
  • 15216-EP2316833A1
  • AB00933189-05
  • AB00933189-06
  • AB00933189_08
  • 461S730
  • A819449
  • Q421136
  • SR-00000000529
  • 1130115-44-4
  • 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE
  • I06-0856
  • SR-00000000529-1
  • BRD-K23984367-001-01-8
  • BRD-K23984367-001-07-5
  • BRD-K23984367-075-15-2
  • Z89277543
  • 2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-
  • 475207-59-1
  • BAY 439006; BAY439006; BAY-439006
  • 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
  • 4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
  • 4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N(SUP 2)-METHYLPYRIDINE-2-CARBOXAMIDE
  • 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate
  • BAX
  • N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea
  • Sorafenib (D3); CM-4307; CM 4307; CM4307;Bay 43-9006 (D3)
  • 1-[4-Chloro-3-(trifluoromethyl)phenyl]-3-[4-[2-(methylcarbamoyl)-4-pyridyloxy]phenyl]urea
  • 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl) ureido) phenoxy)-N-methylpicolinamide
  • 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl) ureido)phenoxy)-N-methylpicolinamide
  • 4-[4-[3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido]phenoxy]-N-methylpyridine-2-carboxamide
  • N-(3-trifluoromethyl-4-chlorophenyl)-N'-(4-(2-methylcarbamoyl pyridin-4-yl)oxyphenyl)urea
  • N-Methyl-4-(4-(3-(3-(trifluoromethyl)-4-chlorophenyl)ureido)phenoxy)pyridine-2-carboxamide
  • 1-[4-Chloro-3-(trifluoromethyl)phenyl]-3-[4-[[2-(methylcarbamoyl)-4-pyridyl]oxy]phenyl]urea
  • 1210608-86-8
  • 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-
  • 2-pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-n-methyl-;sorafenib;4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-n-methyl-2-pyridinecarboxamide;2-pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-n-methyl- sorafenib 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-n-methyl-2-pyridinecarboxamide
  • 2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-
  • 4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)phenoxy)-N-methylpyridine-2-carboxamide
  • 4-(4-((4-chloro-3-(trifluoromethyl)phenyl)carbamoylamino)phenoxy)-N-methylpyridine-2-carboxamide
  • 4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)- N-methylpyridine-2-carboxamide
  • 4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N2-methylpyridine-2-carboxamide
  • 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; BAY 43-9006; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nevaxar; Sorafenib
  • 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-(trideuterio(113C)methyl)pyridine-2-carboxamide
  • 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-picolinamide;tosylic acid
  • 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)-amino]phenoxy}-N-methylpyridine-2-carboxamide
  • 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methyl-pyridine-2-carboxamide
  • 475213-01-5
  • 608-209-4
  • Manganese(4+), chloro[[4,4',4'',4'''-(21H,23H-porphine-5,10,15,20-tetrayl-kappaN21,kappaN22,kappaN23,kappaN24)tetrakis[1-methylpyridiniumato]](2-)]-, chloride (1:4), (SP-5-12)-
  • Manganese(4+), chloro[[4,4',4'',4'''-(21H,23H-porphine-5,10,15,20-tetrayl-N21,N22,N23,N24)tetrakis[1-methylpyridiniumato]](2-)]-, chloride (1:4), (SP-5-12)-
  • N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl) urea
  • N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea
  • N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide